Back to Search Start Over

Mutations in ACY1, the Gene Encoding Aminoacylase 1, Cause a Novel Inborn Error of Metabolism

Authors :
Andrea Superti-Furga
Susanne Schweitzer-Krantz
Heike Olbrich
Udo F. H. Engelke
Verena Mohr
Ron A. Wevers
Manfred Fliegauf
Ralf Moebus
Heymut Omran
Andreas Kispert
Judit Horvath
Niki T. Loges
Jörn Oliver Sass
Polly Weiler
Source :
American Journal of Human Genetics, 78, 401-9, American Journal of Human Genetics, 78, 3, pp. 401-9
Publication Year :
2006
Publisher :
Elsevier BV, 2006.

Abstract

Contains fulltext : 50017.pdf (Publisher’s version ) (Closed access) N-terminal acetylation of proteins is a widespread and highly conserved process. Aminoacylase 1 (ACY1; EC 3.5.14) is the most abundant of the aminoacylases, a class of enzymes involved in hydrolysis of N-acetylated proteins. Here, we present four children with genetic deficiency of ACY1. They were identified through organic acid analyses using gas chromatography-mass spectrometry, revealing increased urinary excretion of several N-acetylated amino acids, including the derivatives of methionine, glutamic acid, alanine, leucine, glycine, valine, and isoleucine. Nuclear magnetic resonance spectroscopy analysis of urine samples detected a distinct pattern of N-acetylated metabolites, consistent with ACY1 dysfunction. Functional analyses of patients' lymphoblasts demonstrated ACY1 deficiency. Mutation analysis uncovered recessive loss-of-function or missense ACY1 mutations in all four individuals affected. We conclude that ACY1 mutations in these children led to functional ACY1 deficiency and excretion of N-acetylated amino acids. Questions remain, however, as to the clinical significance of ACY1 deficiency. The ACY1-deficient individuals were ascertained through urine metabolic screening because of unspecific psychomotor delay (one subject), psychomotor delay with atrophy of the vermis and syringomyelia (one subject), marked muscular hypotonia (one subject), and follow-up for early treated biotinidase deficiency and normal clinical findings (one subject). Because ACY1 is evolutionarily conserved in fish, frog, mouse, and human and is expressed in the central nervous system (CNS) in human, a role in CNS function or development is conceivable but has yet to be demonstrated. Thus, at this point, we cannot state whether ACY1 deficiency has pathogenic significance with pleiotropic clinical expression or is simply a biochemical variant. Awareness of this new genetic entity may help both in delineating its clinical significance and in avoiding erroneous diagnoses.

Details

ISSN :
00029297
Volume :
78
Issue :
3
Database :
OpenAIRE
Journal :
The American Journal of Human Genetics
Accession number :
edsair.doi.dedup.....346fc350282ec1c3ff87ca617dfdc28a
Full Text :
https://doi.org/10.1086/500563